TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Illinois Investigators

Stephanie Gregory, MD

Rush University Medical Center


Chicago, Illinois - 60612
  • CLINICAL TRIALS 6
  • CONDITIONS9
  • INTERVENTIONS9
  • SINCE2006
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

January 2009 - June 2018
Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

September 2009 - June 2013
Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma

October 2006 - October 2016
Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

July 2009 - May 2016
Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma

November 2007 - November 2010
Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade Therapy.

August 2008 - March 2011
Lymphoma

Lymphoma, Non-Hodgkin

Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphoid

Lymphoma, B-Cell

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Mantle-Cell

Burkitt Lymphoma

Placebo

Bevacizumab

Lenalidomide

Rad001

Pralatrexate Injection

Vitamin B12

Folic Acid

Regimen B

Regimen A

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo